We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




New Energy Source for Future Medical Implants

By HospiMedica International staff writers
Posted on 28 Jun 2012
An implantable energy cell powered by glucose could soon be driving neural prosthetics that help patients regain control of limbs.

Researchers at the Massachusetts Institute of Technology (MIT; Cambridge, USA) developed a glucose-based fuel cell that is fabricated on a silicon wafer, much in the same way that semiconductor chips are made, but uses a biocompatible platinum catalyst to strip electrons from glucose molecules, thus mimicking the activity of cellular enzymes that break down glucose to generate adenosine triphosphate (ATP). More...
The silicone fuel cell can generate an electric current of up to 100 µW, which is enough power to drive a neural implant.

According to researchers, the glucose-based fuel cell will most likely first be implemented in the brain, since cerebrospinal fluid (CSF), which envelopes and protects the brain and spinal column, contains enough glucose to power the fuel cell; since only a small fraction of the available power is utilized by the glucose fuel cell, the impact on the brain’s function would likely be small. Also, the CSF is a good location because it contains very few cells, which greatly reduces the chance of an immune response. The study was published in the June 12, 2012, edition of PLoS ONE.

“The glucose fuel cell, when combined with such ultralow-power electronics, can enable brain implants or other implants to be completely self-powered and not require battery replacements, a common problem with electronic implants today,” said senior author Rahul Sarpeshkar, PhD, an associate professor of electrical engineering and computer science at MIT.

The idea of a glucose fuel cell has been around since the 1970s, when scientists showed they could power a pacemaker with one, but the idea was abandoned in favor of lithium-ion batteries, which could provide significantly more power per unit area than glucose fuel cells. These glucose fuel cells also utilized enzymes that proved to be impractical for long-term implantation in the body, since they eventually ceased to function efficiently.

Related Links:

Massachusetts Institute of Technology



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Pediatric Mask
Respire SOFT
Radiofrequency Generator
GX1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.